These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 27000374)

  • 41. Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer.
    Hahn T; Alvarez I; Kobie JJ; Ramanathapuram L; Dial S; Fulton A; Besselsen D; Walker E; Akporiaye ET
    Int J Cancer; 2006 May; 118(9):2220-31. PubMed ID: 16331615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High collagen density augments mTOR-dependent cancer stem cells in ERα+ mammary carcinomas, and increases mTOR-independent lung metastases.
    Shea MP; O'Leary KA; Wegner KA; Vezina CM; Schuler LA
    Cancer Lett; 2018 Oct; 433():1-9. PubMed ID: 29935374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated Macrophages and Neutrophils Infiltration in Breast Tumors and Lung and Liver Metastases.
    Henkels KM; Muppani NR; Gomez-Cambronero J
    PLoS One; 2016; 11(11):e0166553. PubMed ID: 27851813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.
    Szabova L; Chrysovergis K; Yamada SS; Holmbeck K
    Oncogene; 2008 May; 27(23):3274-81. PubMed ID: 18071307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice.
    He L; Zhu Z; Chen S; Wang Y; Gu H
    Cancer Med; 2016 Jun; 5(6):1292-7. PubMed ID: 26992445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells.
    Basu GD; Liang WS; Stephan DA; Wegener LT; Conley CR; Pockaj BA; Mukherjee P
    Breast Cancer Res; 2006; 8(6):R69. PubMed ID: 17156488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.
    Howe LR; Subbaramaiah K; Patel J; Masferrer JL; Deora A; Hudis C; Thaler HT; Muller WJ; Du B; Brown AM; Dannenberg AJ
    Cancer Res; 2002 Oct; 62(19):5405-7. PubMed ID: 12359744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression.
    Qin L; Liao L; Redmond A; Young L; Yuan Y; Chen H; O'Malley BW; Xu J
    Mol Cell Biol; 2008 Oct; 28(19):5937-50. PubMed ID: 18644862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Semaphorin 7a exerts pleiotropic effects to promote breast tumor progression.
    Black SA; Nelson AC; Gurule NJ; Futscher BW; Lyons TR
    Oncogene; 2016 Sep; 35(39):5170-8. PubMed ID: 27065336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MRTF-A mediates the activation of COL1A1 expression stimulated by multiple signaling pathways in human breast cancer cells.
    Meng C; He Y; Wei Z; Lu Y; Du F; Ou G; Wang N; Luo XG; Ma W; Zhang TC; He H
    Biomed Pharmacother; 2018 Aug; 104():718-728. PubMed ID: 29807221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model.
    Almholt K; Juncker-Jensen A; Laerum OD; Danø K; Johnsen M; Lund LR; Rømer J
    Mol Cancer Ther; 2008 Sep; 7(9):2758-67. PubMed ID: 18790756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice.
    Gonçalves RM; Delgobo M; Agnes JP; das Neves RN; Falchetti M; Casagrande T; Garcia APV; Vieira TC; Somensi N; Bruxel MA; Mendes DAGB; Rafacho A; Báfica A; Gelain DP; Moreira JCF; Cassali GD; Bishop AJR; Zanotto-Filho A
    Cancer Lett; 2021 Apr; 502():44-57. PubMed ID: 33429006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.
    Goswami S; Sharma-Walia N
    Oncotarget; 2016 Sep; 7(37):58953-58974. PubMed ID: 27270654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype.
    Valdés-Mora F; Salomon R; Gloss BS; Law AMK; Venhuizen J; Castillo L; Murphy KJ; Magenau A; Papanicolaou M; Rodriguez de la Fuente L; Roden DL; Colino-Sanguino Y; Kikhtyak Z; Farbehi N; Conway JRW; Sikta N; Oakes SR; Cox TR; O'Donoghue SI; Timpson P; Ormandy CJ; Gallego-Ortega D
    Cell Rep; 2021 Apr; 35(2):108945. PubMed ID: 33852842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
    Panagopoulos V; Leach DA; Zinonos I; Ponomarev V; Licari G; Liapis V; Ingman WV; Anderson P; DeNichilo MO; Evdokiou A
    Int J Oncol; 2017 Apr; 50(4):1191-1200. PubMed ID: 28260049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.
    Tury S; Becette V; Assayag F; Vacher S; Benoist C; Kamal M; Marangoni E; Bièche I; Lerebours F; Callens C
    Oncotarget; 2016 Dec; 7(51):85124-85141. PubMed ID: 27835884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice.
    Lanza-Jacoby S; Miller S; Flynn J; Gallatig K; Daskalakis C; Masferrer JL; Zweifel BS; Sembhi H; Russo IH
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1486-91. PubMed ID: 14693742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer.
    Lanza-Jacoby S; Burd R; Rosato FE; McGuire K; Little J; Nougbilly N; Miller S
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6161-9. PubMed ID: 17062693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix stiffness enhances cancer-macrophage interactions and M2-like macrophage accumulation in the breast tumor microenvironment.
    Taufalele PV; Wang W; Simmons AJ; Southard-Smith AN; Chen B; Greenlee JD; King MR; Lau KS; Hassane DC; Bordeleau F; Reinhart-King CA
    Acta Biomater; 2023 Jun; 163():365-377. PubMed ID: 35483629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.